Scaling biotech innovations takes more than great science: it takes great partnerships.
We were delighted to host our partners from AMSilk at our Davis R&D site this week. Together, we’re making industrial-scale spider silk a reality.
Our collaboration has already enabled the world’s first extracellular expression of spider silk proteins and is on the way to unlocking a broad market for spider silk applications 🕸️
With its unmatched strength, flexibility, and biocompatibility, biosilk is redefining materials science. From biomedical applications to textiles, composites, and beyond, AMSilk is leading the way. We’re so proud to apply our strain platform in helping AMSilk get to industrial-scale production.
Bringing novel biomaterials to market isn’t just about technical breakthroughs. It’s about scaling efficiently, reducing risk, and making innovation commercially viable. That’s why strong partnerships in biotech are essential – they accelerate time to market while optimizing costs and reliability. This week we have brought our teams together to ideate, prioritize and plan the development and optimization work for the coming year.
Our partnership has even been highlighted by the World Economic Forum – emphasizing the importance of collaborations for success in biotechnology.
